Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04679324
Status:
WITHDRAWN
Last Update Posted:
2022-11-29
First Post:
2020-12-09
Brief Title:
The Role of Mucosal Microbiome in the Development Clearance and Recurrence of Clostridioides Difficile Infection
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
The Role of Mucosal Microbiome in the Development Clearance and Recurrence of Clostridiodes Difficile Infection
Status:
WITHDRAWN
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
C difficile symptoms preclude participants from attending research study visits
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is being done to identify types of bacteria associated with the lining of the large intestine in people who have recently been diagnosed with C difficile infection to determine if there are features associated with development clearance and recurrence of disease
Detailed Description:
Patients who were recently diagnosed with C difficile infection will undergo assessment of both before treatment and after completing treatment to study the presence of C difficile in the colonic mucosa pre as well as assessment for microbiome and patientclinical factors that may contribute to disease recurrence Assessment will include sigmoid colon biopsies blood draw stool samples and surveys
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None